Linagliptin

• Post Date:

  Jul 09,2025

• Expiry Date:

  Jul 09,2026

• Detailed Description:

  Cas No. :668270-12-0 Product information:
  
  1). Chemacil Name: 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;
  
  2). CAS No.: 668270-12-0;
  
  3). Molecular Formula: C25H28N8O2;
  
  4). Molecular Weight: 472.54;
  
  5). Spec: 99.0%(HPLC);
  
  6). Appearance: White powder;
  
  7). Usage: A novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.
  

• CAS Registry Number:

  668270-12-0

• Synonyms:

  ;8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione;1h-purine-2,6-dione, 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-;

• Molecular Formula:

  C₂₅H₂₈N₈O₂

• Molecular Weight:

  472.5422

• Molecular Structure:

  

• Company:

  Shanghai DND Pharm-Technology Co., Inc.     [ China ]          

• Contact:

  Arron Yu

• Tel:

  021-58783620

• Fax:

  021-58783595

• Email:

  sales@dndpharm.com